{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-010423","form_type":"8-K","ticker":"DWTX","cik":"0001818844","company_name":"Dogwood Therapeutics, Inc.","filed_at":"2023-05-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.825847+00:00","generated_at":"2026-06-14T14:52:47.406354+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Virios Therapeutics regains Nasdaq minimum bid price compliance","bullets":["Received Nasdaq letter on May 24, 2023 confirming compliance with Listing Rule 5550(a)(2).","Closing bid price was at least $1.00 for ten consecutive business days (May 10–May 23, 2023).","Closes the deficiency notice initially received on November 1, 2022 regarding bid price non-compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-010423","json":"https://secwatch.observer/filing/0001558370-23-010423.json","markdown":"https://secwatch.observer/filing/0001558370-23-010423.md","text":"https://secwatch.observer/filing/0001558370-23-010423.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818844/000155837023010423/0001558370-23-010423-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818844/000155837023010423/tmb-20230524x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T14:52:47.406354+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}